Cearvol Diamond X1 vs Signia Pure C&G BCT IX

The Cearvol Diamond X1 is a budget-priced OTC hearing aid that earned a B grade with a SoundScore of 3.7/5 in our lab testing, placing it in the top 45% of OTC devices. At $199, it represents an accessible entry point for those exploring hearing amplification. The Diamond X1's standout performance is in music streaming, scoring 4.1/5—a strong result that sits 2.18 points above the OTC category average. This makes it notably capable for users who prioritize audio entertainment through their hearing devices. Feedback handling is also excellent at 4.5/5, meaning users should experience minimal whistling during normal use. However, speech performance presents limitations. Speech in quiet scores a mixed 2.8/5, and speech in noise registers at 1.7/5. While both metrics technically sit above category averages (+0.03 and +0.22 points respectively), they remain low in absolute terms—important context for anyone prioritizing conversation clarity. Own-voice comfort is another weakness, scoring 1.7/5, which is 0.81 points below the category average and may affect how natural users sound to themselves. The Diamond X1 is best suited for budget-conscious consumers who value music streaming quality and aren't heavily reliant on challenging listening environments. Those who prioritize speech understanding in noise or natural own-voice perception may want to consider alternatives in this price range, such as the higher-scoring Elehear Beyond or Apple AirPods Pro 2.

The Signia Pure C&G BCT IX is a premium behind-the-ear prescription hearing aid released in 2025, earning an A grade with a SoundScore of 4.4/5 in our lab testing. Priced at $3,398, it ranks #16 among 39 prescription hearing aids tested. In our standardized testing, this device demonstrates particular strength in own-voice comfort, scoring 3.8/5—a solid result that sits 1.10 points above the category average. This makes it a noteworthy option for users who prioritize natural sound quality when speaking. Speech clarity also performs well, with speech-in-quiet at 3.8/5 (+0.39 points above average) and speech-in-noise at 2.5/5 (+0.43 points above average), though the latter remains mixed in absolute terms despite beating the category benchmark. Feedback handling presents an interesting picture: at 4.2/5, it's strong in absolute terms, though it falls 0.52 points below the category average of 4.72/5. Music streaming scores 2.7/5, essentially matching the category average. The device features rechargeable batteries, iPhone and Android streaming, and hands-free functionality. While the Pure C&G BCT IX delivers solid overall performance, shoppers in this premium price tier should note that competitors like the Phonak Sphere Infinio and Oticon Intent score higher in our testing. Budget-conscious buyers may also find comparable sound quality at lower price points from options like the Rexton Reach R-Li T80 at Costco. This hearing aid is best suited for users who value own-voice naturalness and reliable speech clarity in everyday listening situations.